Aurora Cannabis (NYSE:ACB) has captured investors' imaginations. Due in part to its aggressive acquisition strategy, the Canadian marijuana company has placed itself on track to become the largest producer in the world -- at a time when the global cannabis market is enjoying explosive growth. In turn, Aurora's stock is up more than 1,800% in the past three years, earning fortunes for its shareholders along the way.

If you'd like to learn more about Aurora Cannabis, the following five charts can help you quickly get up to speed on the core aspects of its business.

If you're looking to buy a marijuana stock, Aphria (NYSE: APHA) and Canopy Growth(NYSE: CGC) should probably be on your list for consideration. They're two of the largest Canadian cannabis producers in terms of production capacity. Both Aphria and Canopy Growth are well positioned in the Canadian adult-use recreational marijuana market and in international medical cannabis markets.

Canopy Growth has been the bigger winner so far this year, with its shares jumping 50% while Aphria has delivered a year-to-date gain of 18%. But which stock is the better pick now?  

Wonder drug or modern-day snake oil? Appearing in stores and online in the form of body lotions, capsules, tinctures, edible gummies and bottled water, CBD has exploded in popularity as a way to reap the supposed health benefits of marijuana without the high that comes with it.

According to a new statistical study featured in the American Medical Association’s online journal, there has been an increase in the number of pregnant women consuming cannabis as compared to previous years. The study shows that the number of women choosing to use cannabis during their gestation period between 2016 and 2017 increased by 7 %. This study’s results vary significantly with the results of a previous study conducted between 2002 and 2003. According to the previous study, which used the same parameters, only 3% of women during this period opted to use cannabis.

Aurora Cannabis (TSX:ACB)(NYSE:ACB) shares are currently trading at a rather lofty 500 times price-to-earnings multiple.

But are fears that Canada’s second-largest publicly traded cannabis stock is overvalued overblown?

Let’s take a closer look at why ACB’s current price-to-earnings multiple might not have  much to do with the company’s potential as an attractive long-term growth prospect.

Aurora’s market capitalization right now sits at about $10 billion, which means that at a forward price-to-earnings ratio of 500 times the market is currently expecting the company to earn somewhere in the neighbourhood of $200 million next year ($10 billion divided by 500).

It's probably not much of an exaggeration to state that most investors' eyes are "on the green." Marijuana is arguably the hottest investment idea of this generation, with global legal sales potentially growing to between $50 billion and $75 billion by 2029/2030, up from around $12 billion in 2018. Given that most cannabis sales are still tied up in the black market, there's ample opportunity for legalizations in the U.S. and around the world to push a steady stream of these illicit transactions into legal channels.

But within the cannabis industry lies perhaps the most exciting trend of all: the rise of cannabidiol (CBD).

Saskatchewan may be seeing more hemp crops in the future.

Andrea Eriksson, business development officer at Norquest College in Edmonton, spoke at the Farm Progress Show in Regina this past week to educate farmers about hemp crops and the recent growth of the industry.

Saskatchewan is second in the country in the crop’s production, behind only Alberta.

Eriksson said the industry has “untapped potential” but added there is a lot of confusion as to what exactly hemp is. Although it is considered a cannabis plant, it is not marijuana.

Cannabis stocks have come off the boil since the start of 2019 and there appears to be little life left in the sector as fears of a trade war and a weaker global economy weigh on the outlook for consumer products. This is being exacerbated by growing fears that marijuana stocks are in a bubble and many are heavily overvalued.

Right now, few industries offer greater long-term growth potential than the legal marijuana industry. On Wall Street, peak sales projections for the cannabis industry have come in as high as $166 billion. The analyst behind this lofty forecast, Bank of America's Christopher Carey, also suggests that marijuana could disrupt industries that today combine for $2.6 trillion in annual sales.

Despite its apparent reputation, Vancouver Island remains behind other regions of the province when it comes to issuing marijuana retail licenses.

According to the latest available statistics from the Liquor and Cannabis Regulation Branch (LCRB), the region of Vancouver Island, Powell River and Gulf Islands is home to six licensed non-medicinal private retail stores. That is three less than the Greater Vancouver and Sunshine Coast region, and 12 less than the Interior and North. That region also leads all regions with paid, complete applications (221), paid but incomplete applications (23) and applications referred to local government or Indigenous Nations (169).